Navigation Links
Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
Date:4/29/2011

EAST BRUNSWICK, N.J., April 29, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that it has named Richard Crowley Executive Vice President of Biopharmaceutical Operations, effective April 30, 2011.  Mr. Crowley brings extensive pharmaceutical industry knowledge and experience and will lead the overall management of Savient's manufacturing, regulatory, quality, project management and KRYSTEXXA® product teams.  Mr. Crowley will report directly to Mr. John H. Johnson, Chief Executive Officer of Savient.  

"Rick brings to Savient nearly 25 years of experience in the biotechnology industry along with a proven history of success in leadership roles," said Mr. Johnson.  "His demonstrated ability to achieve strategic corporate goals, combined with his in-depth knowledge of research, development and manufacturing, makes him a tremendous asset to our company as we continue to advance our U.S. launch efforts to bring KRYSTEXXA to patients suffering from refractory chronic gout, as well as pursue opportunities to expand into markets around the world."

Mr. Crowley joins Savient from ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, where he served as Senior Vice President of Biopharmaceutical Operations since 2006.  Prior to that position, he served as Vice President of Manufacturing and General Manager.  Mr. Crowley has also spent significant time at BASF Bioresearch Corporation, Genencor International, Eastman Kodak Company and Monsanto Company.  

Savient Expands KRYSTEXXA Team Following Market Introduction

In addition to Mr. Crowley's appointment, Savient today announced four new functional leaders.  

"We are strategically enhancing our management team to advance KRYSTEXXA's introduction into the market," said Mr. Johnson. "Each of these new members has
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
11. Savient Pharmaceuticals To Hold First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... report is available in its catalogue: ... and Technologies for Advanced Drug Delivery ... Administration http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
(Date:1/14/2014)... HAMILTON, N.J. , Jan. 14, 2014 InformEx, ... buyers and sellers of high-value chemistry, will hold the 30 ... Miami Beach Convention Center from January 21-24. ... than 3,500 attendees from top pharmaceutical, fine chemical and specialty ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
(Date:4/18/2014)... Fraser University psychologists have made a brain-related discovery ... attention-deficit disorders. , This discovery opens up the ... or suppress a specific brain activity that the ... , The Journal of Neuroscience has ... John McDonald, an associate professor of psychology and ...
(Date:4/17/2014)... chronic inflammation in non-cancerous prostate tissue may have nearly ... those with no inflammation, according to results of a ... Kimmel Cancer Center. , The link between persistent inflammation ... high-grade prostate cancer those with a Gleason score ... the most aggressive and rapidly growing prostate cancers. , ...
(Date:4/17/2014)... of Experimental Biology and Medicine a ... and Paul Kenis in the Institute of Genomic ... of Illinois Urbana-Champaign describe their recent work on ... variety of cell functions including energy metabolism, signaling, ... in regulating normal cellular behavior, redox status has ...
(Date:4/17/2014)... biology team has created a new technology for ... could travel the body and selectively target cancer ... biological devices that monitor and modify human physiology ... However, no existing technology enabled bioengineers to build ... and respond in a customized fashion. , "The ...
(Date:4/17/2014)... one in five infants in the United States annually ... several months after birth. Research into probiotic use for ... April 1, 2014 issue of the British Medical ... "Probiotics and Infant Colic," concluding that the use of ... did not reduce crying or fussing in infants ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Building 'smart' cell-based therapies 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... , , ... personal injury attorney John David Hart has filed 29 lawsuits against ... Medtronic USA, Inc. and Medtronic Puerto Rico Operations Co., in connection ... fractures which could result in serious injury or death. , ...
... , , , ... today announced its first device, the ZOOM-100DC brain electrical activity ... U.S. Food and Drug Administration under section 510(k) of the ... electroencephalogram (EEG) device capable of recording and displaying EEG waveforms ...
... SCOTTSDALE, Ariz., Aug. 11 ... of interoperable workflow solutions that advance the quality and safety of ... e fe r ral , its portal-based ... a streamlined, patient-centric and highly accountable process for tracking referrals. ...
... , , HOUSTON, Aug. 11 ... on workers, compensation, has announced its recent network certification in the ... few to achieve this certification, which covers all 159 counties in ... to leading workers, compensation providers for third party administrators, managed care ...
... , , HERMOSA BEACH, Calif., ... Cancer (PADRES), a non-profit organization committed to improving the quality of life for ... Volleyball match as part of the 2009 AVP CROCS SLAM BUD ... . , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090811/LA59829 ) , , ...
... National Non-profit Provides No ... ... know that cataracts are the leading cause of vision loss among adults 55 and ... cataract development. , , , , ,Moreover, a recent study out of the University of ...
Cached Medicine News:Health News:Texas Law Firm Files Multiple Suits Against Medtronic as Deadline Approaches 2Health News:BrainScope(TM) Receives FDA Clearance for Portable EEG Device 2Health News:BrainScope(TM) Receives FDA Clearance for Portable EEG Device 3Health News:Carefx's New Referral Management Solution Increases Hospital Referral Volume, Enhances Collaboration Among Specialists, PCPs and Patients 2Health News:Carefx's New Referral Management Solution Increases Hospital Referral Volume, Enhances Collaboration Among Specialists, PCPs and Patients 3Health News:Carefx's New Referral Management Solution Increases Hospital Referral Volume, Enhances Collaboration Among Specialists, PCPs and Patients 4Health News:Rockport Healthcare Group Continues to Grow Coverage Area With New Work Comp Network Certification in Georgia 2Health News:Kevin Nealon, Jordan Farmar, Walter Perez, Cristian de la Fuente and Other Celebrities Participated in Beach Volleyball Match for Children With Cancer 2Health News:Kevin Nealon, Jordan Farmar, Walter Perez, Cristian de la Fuente and Other Celebrities Participated in Beach Volleyball Match for Children With Cancer 3Health News:EyeCare America Works to Prevent Blindness Caused by Cataracts 2Health News:EyeCare America Works to Prevent Blindness Caused by Cataracts 3
... HIBICLENS bonds with ... a protective, germ-killing field. ... fast acting antimicrobial effect, ... irritation potential promotes compliance ...
... solution, allows the user to prep one ... in less than 2-minutes. It also utilizes ... surgical scrubbing and healthcare personnel handwashing. ACTIPREP ... provide a tacky surface for drapes to ...
... This multi-purpose topical gel contains 10% ... broad-spectrum germicidal action. As a pre-operative prep, ... pooling of prepping solutions under the patient, ... The Gel is also approved as a ...
... Scrub is a gentle and effective surgical ... dryness. Povidone Iodine is known to kill ... bacteria, fungi, viruses, protozoa and yeasts. It ... step in patient pre-operative prepping, as well ...
Medicine Products: